These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20197773)

  • 1. Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.
    Lee JM; Choudhury RP
    Nat Rev Rheumatol; 2010 Mar; 6(3):123-4. PubMed ID: 20197773
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.
    Navarro-Millán I; Goyal P; Safford MM
    Rheumatology (Oxford); 2019 Jun; 58(6):933-934. PubMed ID: 30272226
    [No Abstract]   [Full Text] [Related]  

  • 3. Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins.
    Gazi IF; Boumpas DT; Mikhailidis DP; Ganotakis ES
    Clin Exp Rheumatol; 2007; 25(1):102-11. PubMed ID: 17418000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cardiovascular risk in rheumatoid arthritis: a dual role for statins.
    Bisoendial RJ; Stroes ES; Kastelein JJ; Tak PP
    Nat Rev Rheumatol; 2010 Mar; 6(3):157-64. PubMed ID: 20142814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in rheumatoid arthritis--two birds with one stone?
    Klareskog L; Hamsten A
    Lancet; 2004 Jun; 363(9426):2011-2. PubMed ID: 15207947
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications.
    Pieringer H; Pichler M
    QJM; 2011 Jan; 104(1):13-26. PubMed ID: 21068083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis].
    Kleinert S; Krueger K
    Z Rheumatol; 2011 Aug; 70(6):464-72. PubMed ID: 21863467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis and cardiovascular disease: the role of systemic inflammation and evolving strategies of prevention.
    Snow MH; Mikuls TR
    Curr Opin Rheumatol; 2005 May; 17(3):234-41. PubMed ID: 15838230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pleiotropic effects of statins in rheumatoid arthritis.
    Aminifar E; Tavakkol Afshari HS; Sathyapalan T; Abbasifard M; Sahebkar A
    J Pharm Pharmacol; 2023 Jul; 75(7):910-920. PubMed ID: 37027319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
    Danninger K; Hoppe UC; Pieringer H
    Int J Rheum Dis; 2014 Jul; 17(6):606-11. PubMed ID: 24931356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins in rheumatology.
    Soubrier M; Roux C
    Joint Bone Spine; 2006 Mar; 73(2):159-68. PubMed ID: 16300987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis.
    Boyer JF; Cantagrel A; Constantin A
    Curr Vasc Pharmacol; 2008 Jul; 6(3):218-27. PubMed ID: 18673161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and rheumatoid arthritis.
    Bhatia GS; Sosin MD; Connolly DL; Davis RC
    Lancet; 2004 Nov 20-26; 364(9448):1853; author reply 1855. PubMed ID: 15555660
    [No Abstract]   [Full Text] [Related]  

  • 14. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.
    McCarey DW; McInnes IB; Madhok R; Hampson R; Scherbakov O; Ford I; Capell HA; Sattar N
    Lancet; 2004 Jun; 363(9426):2015-21. PubMed ID: 15207950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Risk Assessment and Therapeutic Implications in Rheumatoid Arthritis.
    Halacoglu J; Shea LA
    J Cardiovasc Transl Res; 2020 Oct; 13(5):878-890. PubMed ID: 32080804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--NSAID a possible cause?].
    Pind R
    Ugeskr Laeger; 2011 Mar; 173(11):837; author reply 837. PubMed ID: 21520672
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determining cardiovascular risk in patients with rheumatoid arthritis: waiting for trial outcomes is not recommended].
    Nurmohamed MT
    Ned Tijdschr Geneeskd; 2011; 155(29):A3485. PubMed ID: 21791135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.
    Full LE; Monaco C
    Cardiovasc Ther; 2011 Aug; 29(4):231-42. PubMed ID: 20553292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of anti-inflammatory and antidyslipidemic effects of fenofibrate and statins on rheumatoid arthritis.
    Goto M
    Mod Rheumatol; 2010 Jun; 20(3):238-43. PubMed ID: 20143119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis.
    El-Barbary AM; Hussein MS; Rageh EM; Hamouda HE; Wagih AA; Ismail RG
    J Rheumatol; 2011 Feb; 38(2):229-35. PubMed ID: 21041278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.